Neurofeedback For Addiction Recovery: Why It’s A Game Changer

Neurofeedback is often described as brain training that quiets cravings. The research is more mixed: some reviews are encouraging, the most quoted trial is often misread, and a few careful studies found little added benefit. For now it is best understood as one part of a treatment plan, not the plan itself.

Neurofeedback turns up on a lot of addiction treatment pages, usually described as brain training that quiets cravings and makes recovery stick. If you or someone close to you is weighing treatment for alcohol or drug use, it is fair to ask whether that description holds up. The studies have a real answer, and it is more modest than the marketing.

💡
Can neurofeedback help someone recover from substance use?
The evidence is encouraging but early. Reviews of mostly small studies report less craving when neurofeedback is added to standard treatment, and one older trial found better abstinence among people who completed it. Other controlled trials found little extra benefit. It is studied as an add-on to therapy and, where prescribed, medication, not as a stand-alone treatment.

What a Session Involves

Small sensors rest on the scalp and record the brain's electrical activity, the same signal an EEG measures. Software turns that signal into something you can see or hear, such as a picture that sharpens or a tone that plays when your brain produces the pattern the session is training toward. Over many sessions, people learn to produce that pattern more readily. Nothing is sent into the brain; the equipment only listens. That loop of measuring, feeding back and practicing is the core of how neurofeedback works, whatever it is being used for.

Close-up of EEG sensors placed on the scalp before a neurofeedback session
Neurofeedback at Redefine
Sensors placed before a session at the Scottsdale center.

Why Addiction Research Looks at the Brain's Own Signals

The National Institute on Drug Abuse describes addiction as a chronic, relapsing disorder, and considers it a brain disorder because it involves changes to the circuits that handle reward, stress and self-control. Those changes can last well after someone stops using. That framing is why researchers began asking whether training the brain to regulate itself could help with the things that make early recovery hard: craving, stress and staying focused on treatment.

Most of the older work used a method called alpha-theta training, sometimes preceded by training aimed at attention. Newer studies also use fMRI neurofeedback, where people see activity in a specific brain region and try to change it. The two are different tools, and the research on them is reviewed separately.

What the Studies Found So Far

Reviews that lean positive, with caveats

A 2008 review that rated the evidence by the field's own standards called alpha-theta training "probably efficacious" when it was combined with residential treatment programs, for alcohol and for stimulant or mixed substance use. That is a middle rating, below the top tier. More recent reviews point the same way. A 2025 systematic review of 32 studies found that reduced craving was the most common result and concluded that neurofeedback shows promise as an adjunct to standard care. A 2025 meta-analysis of 17 randomized trials, with 662 participants in total, found a significant effect on addiction symptoms, while noting large differences between the studies in how neurofeedback was delivered.

The fMRI work is less settled. A 2024 review of 16 studies described the evidence for changes in brain function and craving as early and inconsistent, and called for placebo-controlled trials.

The 2005 trial behind the most quoted number

Much of what you read about neurofeedback and addiction traces back to one randomized trial published in 2005. It enrolled 121 adults in an inpatient substance use program. Those assigned to neurofeedback received 40 to 50 sessions on top of treatment; the comparison group received extra time in the regular program instead. The neurofeedback group stayed in treatment significantly longer, and a year later abstinence was higher among the people who had completed the full protocol.

Those details matter. The abstinence figure counted people who finished the protocol, not everyone who started. The comparison group did not receive a sham version of neurofeedback, so expectation and attention could account for part of the difference. And the psychological changes the study reported were on 5 of 10 scales of a personality inventory, not across the board. Many summaries repeat the abstinence figure without those qualifiers. The trial is a reasonable reason for interest. It is not proof that neurofeedback keeps people sober.

Trials that found little added benefit

Some careful studies came back mostly empty. In a 2022 randomized trial of 93 adults in outpatient substance use treatment in Norway, 20 sessions of neurofeedback added to usual care made no difference to quality of life, drug use, sleep, anxiety or depression; the only measurable change was less restlessness. A 2018 randomized trial of 42 patients found neurofeedback plus usual care was no more effective than usual care alone for craving, impulsivity or drug use. A 2018 review summed up the problem: decades of work have produced too few well-designed trials to draw firm conclusions.

Put together, the research says neurofeedback may help some people with craving and with staying in treatment, that results depend heavily on how it is delivered, and that nobody can yet say who will benefit.

Is It a Replacement for Therapy or Medication?

No. Every trial described here tested neurofeedback alongside regular treatment, never instead of it. The National Institute on Drug Abuse notes that substance use disorders are treatable and that there are safe, effective medications and behavioral therapies for them. Neurofeedback, at its best in the current research, adds to that work.

That shapes what to expect. Neurofeedback is something you would add to a plan that already includes therapy, and judge by how you are doing over weeks, not by a figure from a study. If you are considering it, ask what it is meant to help with in your case and how progress will be judged. A good clinic answers both plainly, and who runs and supervises the sessions matters just as much when choosing a neurofeedback provider. If you take medication for substance use or a related condition, any change to it is a decision to make with the prescriber, whatever else you add.

How Neurofeedback Fits Into Care at Redefine

Redefine Wellness & Treatment is an outpatient center in Scottsdale for adults, and substance use is among the conditions it treats. Neurofeedback is an integral part of treatment there, and how much of it each person receives varies with their treatment plan, which is built after an assessment. For substance use it remains an active area of research, so neurofeedback at Redefine is used next to individual therapy, group work and the other care the plan calls for, never on its own.

A day in Redefine's intensive outpatient program may include neurofeedback among its other blocks, though not every client has every modality each day.

If you are in distress or experiencing a mental health crisis, please call or text 988, or go to the nearest emergency department.

❓
Common Questions About Neurofeedback and Recovery

Neurofeedback is noninvasive, since the sensors only record activity, and studies generally describe it as well tolerated. It is not free of side effects. In a sham-controlled study, most participants reported some short-lived effects during training, and reviews list headache, drowsiness and nausea among the more common ones. Poorly chosen training can also cause unwanted effects, which is why it should be run and adjusted by a qualified clinician.

The trials described here used between 20 and 50 sessions, and one review of alcohol studies only included programs of at least 10. That range reflects research protocols, not a standard course. At Redefine, how much neurofeedback someone receives depends on their treatment plan, so there is no fixed number to expect before an assessment.

Not in any way the research can show yet. The 2008 review gave the same middle rating to EEG neurofeedback programs for alcohol and for stimulant or mixed substance use, in both cases combined with residential treatment. The fMRI studies have covered alcohol, tobacco and cocaine, but their results on craving are still inconsistent, so it is too early to rank one substance above another.

Possibly, though the evidence is mixed. The 2005 inpatient trial reported improvements on several psychological scales, while the 2022 outpatient trial found no difference in anxiety or depression. Neurofeedback for depression and anxiety is itself an active area of research, so it is best treated as one part of care for those symptoms, alongside therapy.

No. A qEEG is a recording that maps brain activity for assessment, while neurofeedback is a training process that uses live feedback over many sessions. They use similar sensors, which is why they get confused. At Redefine, qEEG brain mapping is available on request and is separate from neurofeedback, not a standard part of the programs.

📚
Resources & References
Research and agency sources cited in this article
1
National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction. Drug Misuse and Addiction.
2
National Institute on Drug Abuse. Treatment.
3
Sokhadze TM, Cannon RL, Trudeau DL. EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. Applied Psychophysiology and Biofeedback. 2008.
4
Scott WC, Kaiser D, Othmer S, Sideroff SI. Effects of an EEG biofeedback protocol on a mixed substance abusing population. American Journal of Drug and Alcohol Abuse. 2005.
5
Fathi M, Ebrahimi MN, et al. A systematic review on the role of EEG and fMRI-neurofeedback training in the treatment of substance use disorders and behavioral addiction. Psychiatry Research. 2025.
6
Wan H, Chen B, et al. Effect of EEG neurofeedback therapy on addiction disorders: a systematic review and meta-analysis. Addiction. 2025.
7
Murphy E, Poudel G, et al. Real-time fMRI-based neurofeedback to restore brain function in substance use disorders: a systematic review of the literature. Neuroscience and Biobehavioral Reviews. 2024.
8
Gabrielsen KB, Clausen T, et al. Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial. Journal of Psychiatry and Neuroscience. 2022.
9
Fielenbach S, Donkers FCL, Spreen M, Bogaerts S. Effects of a theta/sensorimotor rhythm neurofeedback training protocol on measures of impulsivity, drug craving, and substance abuse in forensic psychiatric patients with substance abuse: randomized controlled trial. JMIR Mental Health. 2018.
10
Luigjes J, Segrave R, et al. Efficacy of invasive and non-invasive brain modulation interventions for addiction. Neuropsychology Review. 2018.
11
Dousset C, Kajosch H, et al. Preventing relapse in alcohol disorder with EEG-neurofeedback as a neuromodulation technique: a review and new insights regarding its application. Addictive Behaviors. 2020.
12
Rogel A, Guez J, et al. Transient adverse side effects during neurofeedback training: a randomized, sham-controlled, double blind study. Applied Psychophysiology and Biofeedback. 2015.
13
Hammond DC. First, do no harm: adverse effects and the need for practice standards in neurofeedback. Journal of Neurotherapy. 2008.
14
Patel K, Sutherland H, et al. Effects of neurofeedback in the management of chronic pain: a systematic review and meta-analysis of clinical trials. European Journal of Pain. 2020.
Not Sure Which Parts of Treatment You Need?
You do not need to know which modality or level of care fits before you call. Tell the admissions team what you are dealing with, what you have tried and where it fell short, and they can help you work out whether Redefine's approach fits.
📍 Scottsdale, Arizona

Written By

Brenna Gonzales, LPC, SEP, CMAT

Brenna Gonzales is a Licensed Professional Counselor (LPC), Somatic Experiencing Practitioner (SEP), and Certified Multiple Addiction Therapist (CMAT) specializing in trauma recovery, nervous system regulation, and evidence-based mental health treatment at Redefine Wellness & Treatment.

View the Redefine clinical team

Share

Table of Contents

Last Review & Update: November 6, 2026

The Path to Healing Starts With A Conversation.

Redefine is a Scottsdale-based outpatient center offering flexible mental health programs tailored to your needs. Our admissions team is here to help you.

Related Posts

Clinical Insights You Can Trust

a client rests her eyes and notices tension in her face and neck in a calm session

DBR vs. EMDR: How These Trauma Therapies Differ

Deep Brain Reorienting and EMDR often come up as a pair, especially
A therapist explaining a point to a client during a Deep Brain Reorienting session

What Happens During a Deep Brain Reorienting Session?

Walking into a first Deep Brain Reorienting session is easier when you
A clinician sketching a simple diagram on a notepad while a client watches

What Is Deep Brain Reorienting and How Does DBR Work?

Deep Brain Reorienting has a name that sounds like surgery and a

Take the first step toward improving your mental well-being today

Compassionate treatment, lasting change. Let’s take the next step together.

Check Your Insurance Coverage

white redefine logo

 

Transformative wellness that restores balance, inspires growth, and empowers your wellbeing

 
LegitScript Certified badge
brain paint authorized provider seal of approval

Quick Links

Therapies

Retreats

Contact Information